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A B S T R A C T
Age-related physiological variations of body composition concern both the fat-free mass (FFM) and the fat mass (FM).
These variations expose the elderly person to the risk of malnutrition and could lead to conditions of disability. This pa-
per aims to review the current state of knowledge on body composition in the aged population. The pattern of qualitative
variations in body composition in old age is fairly well defined. In adulthood, the physiological variation of body mass
involves a first increasing phase followed by a decreasing trend. The reduction is due mainly to the loss of fat-free mass,
especially muscle mass. Total body water and bone mass also decrease. Fat mass tends to decrease and the reduction
seems to be due mainly to the loss of subcutaneous fat. The quantitative aspects of the age of onset, rate and intensity of
the physiological variations are still not completely clear. This poor quantitative definition is due to the variable and
multifactorial phenomenology of ageing, the heterogeneity of assessment techniques and sampling models, and the lim-
ited number of empirical observations in oldest-old individuals.
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Introduction
Ageing is a continuous and gradual process. It is char-
acterized by great variability among populations, among
individuals and among organs of the same individual.
This variability involves different rates and ways of age-
ing, and it depends on environmental, cultural and ge-
netic characteristics as well as the presence or absence of
pathological conditions.
Knowledge of body composition variations in ageing
comes mainly from research on populations of industrial-
ized countries (Table 1). The few cross-cultural studies
show that, in spite of the significant quantitative differen-
ces in body composition among different ethnic groups1,
inter-population age-related patterns of variation are
very homogeneous2–12.
Age-related physiological variations of body composi-
tion concern both the fat-free mass (FFM), which in-
cludes the skeleton, muscles and body water, and the fat
mass (FM). These variations expose the elderly person to
the risk of malnutrition and could lead to conditions of
disability13–16. In fact, reduced muscle mass and bone
mass influence the nutritional, functional, endocrine and
cognitive status, as well as the comorbidity. On the other
hand, overweight is often associated with limitations of
function and mobility17,18. Moreover, visceral obesity is
related to cardiovascular disease and diabetes. The clas-
sic U-shaped curve, showing the relationship between
body mass index (BMI) and mortality, derives from the
different and independent effects of the deficiency of
FFM (left part of the curve) and the excess of FM (right
part)19. However, it has been observed that BMI values
associated with the risk of mortality increase with age
and that overweight is linked to better survival in ad-
vanced age20. This pattern of relations has been shown
by the Baltimore Longitudinal Study on Aging21 and
more recently by the National Longitudinal Study of Ca-
nadian Adults22.
The definitions proposed in the literature for ageing
distinguish physiological decline from disease-related va-
riations23. In the absence of disease, the ageing process is
generally referred to as »normal« or »physiological«.
»Primary« ageing is also used24. Successful ageing is used
when deleterious effects are minimized25. In the presen-
ce of diseases, which occur with high frequency in elderly
people, the terms »usual«, »pathological« and »second-
ary« are used.
A major goal of geriatrics and gerontology is the defi-
nition of body composition variability in ageing, with the
aim of distinguishing the »physiological« from the »pa-
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thological« condition. The last few decades have seen a
marked increase in research on age-related changes in
body composition, although the over 80-year-old popula-
tion is still relatively poorly studied. Moreover, the stud-
ies have been conducted with different techniques and
different experimental sampling approaches. Data have
been obtained mainly from cross sectional studies, or
short term follow-up, which are relatively simple and
economical. The age-related changes are inferred from
the comparison of the mean values of the different co-
horts. As discussed by Arking26, this procedure has sev-
eral serious drawbacks: it does not distinguish the effects
of ageing from the effects of the cohort (it may be that
each cohort undergoes different and specific growth con-
ditions, as exemplified by secular trend phenomena); it
also suffers from the effects of selective mortality.
From the theoretical point of view, the data of a longi-
tudinal study, which can also be reorganized in the form
of cross sectional data, are generally considered more re-
liable than the data of a cross sectional study. However,
the longitudinal approach is also not immune from draw-
backs: it does not distinguish the effects of ageing from
the effects of the period; it often uses samples selected on
the basis of socio-economic characteristics; it requires
long-term economic and human resources26. Table 1 shows
an annotated selection of longitudinal studies carried out
in various parts of the world on anthropometric and body
composition variations in the elderly population.
A good methodological approach is to integrate cross
sectional and longitudinal studies. A recent interesting
study27 simultaneously examined the effect of age and
the effect of birth cohort due to the growing obesity epi-
demic. The authors found that, at the same age, later co-
horts had greater fat mass than earlier cohorts (increase
of %FM per birth year: 0.32% in men and 0.16% in
women).
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TABLE 1
ANTHROPOMETRIC AND BODY COMPOSITION LONGITUDINAL STUDIES















1996 9,423 25+ A, BC (DXA)
Cardiovascular Health Study CHS USA 1989 5,888 65+ BC (BIA, DXA)
EURONUT-SENECA Study SENECA Europe 1988 2,586 75–80 A




Fredericton 80+ Study Fredericton Canada 1998 238 80 A
Göteborg Study H70 Sweden
1971 1,148 70




Health, Aging & Body
Composition Study
Health ABC USA
1997 3,075 70–79 A, BC (CT, DXA)
Invecchiare in Chianti Study InCHIANTI Italy 923 65+ A, BC (CT)
Italian Longitudinal Study on Aging ILSA Italy 1992 5,493 65–84 A
Longitudinal Aging Study Amsterdam LASA Netherlands 1992 3,017 55–85 A, BC (BIA)
Maastricht Aging Study MAAS Netherlands 1992 2,043 24–81 A
MacArthur Study of Successful Aging MacArthur USA 1988 1,189 70–79 A
National Institute for Longevity Sci-
ences Longitudinal Study of Aging
NILS-LSA Japan
1997 2,300 40–79 A, BC (DXA)
National Population Health Survey NPHS Canada 1994 17,276 0+ A
NHANES I Epidemiologic Follow-up
Study
NHEFS USA
1971 14,407 25–74 A
Normative Aging Study NAS USA 1963 2,280 (M) 21–81 A
Rancho Bernardo Study Bernardo USA 1972 1,000–6,000 20+ A
Rotterdam Study Rotterdam Netherlands 1990 7,983 55+ A, BC (DXA)
The New Mexico Aging Process Study NMAPS USA 1978 780 65–98 A
* Age group represents the age at the baseline examination. A – anthropometric measurements, BC – body composition, CT – com-
puted tomography, DXA – dual energy x-ray absorptiometry, BIA – bioelectrical impedance analysis, M – men, W – women
In general, the incompleteness of the data and the het-
erogeneity of experimental designs and assessment tech-
niques indicate the need of meta-analyses aimed at defin-
ing the state of knowledge and the major goals of research
on variations of body composition in the aged population.
This paper aims to review the current state of knowl-
edge on body composition in the aged population.
Age-related Weight and BMI Variations
Most studies on ageing analyze weight and BMI varia-
tions (a selection of longitudinal studies in Table 1). Re-
search conducted in industrialized countries indicates a
tendency to an increase of body weight and BMI through-
out life. The Fels longitudinal study estimated an age-re-
lated increasing trend from 40 to 66 years of age in both
men (average annual rate: weight, 0.3 kg/year; BMI, 0.11
kg/m2/year) and women (average annual rate: weight,
0.55 kg/year; BMI, 0.22 kg/m2/year)28. The increase re-
mains virtually constant until the time at which the
trend reverses.
The age at which the weight reduction begins has still
not been defined, with estimates varying between 60 and
80 years. The weight loss is more precocious in men11. It
has been determined that this weight decrease involves
over 60% of individuals29. However, the reduction is not
constant and there may be oscillations, as recently shown
in the longitudinal Health, Aging, and Body Composition
Study30.
The Göteborg H70 longitudinal study showed that
BMI decreased significantly in both sexes after age 70,
and there was a gender difference in the trend, as fema-
les decreased more than males31. The cross sectional survey
from the InCHIANTI study showed that BMI increased
with age up to 45–54 years in men and up to 65–74 years
in women, after which it declined32. The Italian Longi-
tudinal Study on Aging showed that BMI decreased in
both sexes between 65 and 85 years; the trend was more
regular in men and particularly after 75 years33.
The aetiology of weight loss in the elderly is complex.
It may be voluntary or involuntary. The most important
voluntary factors are the restriction of food intake and/or
the increase of physical activity. Involuntary factors in-
clude sarcopenia, starvation and cachexia. Sarcopenia
only affects FFM and can be considered, within limits, a
physiological phenomenon. Starvation, related to the re-
duction of nutritional intake, is due to the anorexia of the
elderly and results in a decrease of FFM and FM. Finally,
cachexia is a condition of severe weight loss secondary to
pathological conditions such as cancer and immunodefi-
ciency syndrome; also in this case, the weight loss in-
volves both FFM and FM.
Age-related Fat-free Mass Variations
The FFM progressively increases in the first phases of
the life-cycle and reaches a peak in the fourth decade, af-
ter which it begins to decrease. The reduction of FFM is
the most important part of the involuntary weight varia-
tion in the elderly34,35. The age-related FFM loss is
smaller in active than sedentary individuals, as shown by
the Longitudinal Research in Healthy Swiss Adults36 and
by the Fels Longitudinal Study28. There is no general
consensus on the magnitude and mean rate of the FFM
decrease. As reviewed by Evans37, FFM decreases by aro-
und 15% between the third and eighth decade. The re-
view by Young38 shows that the rate of decrease of FFM is
6.3% per decade and the percentage reduction can reach
30%. According to the longitudinal study by Hughes et
al.29, after 60 years of age FFM decreases in men (2.0%
per decade) but not in women. Strikingly similar esti-
mates were found in the FELS Longitudinal Study39.
Studies of body composition at the molecular level
show that the reduction of total body protein is particu-
larly evident after 65 years and can be estimated at 5%
overall (see the review by Heymsfield et al.40). Studies at
the atomic level show that total body potassium de-
creases at a rate of 7.20+/1.00 mg/kg per year in women
and 9.16+/0.96 mg/kg per year in men41.
Muscle mass
The depletion of FFM is largely attributable to the
muscle component. Sarcopenia, i.e. the progressive and
irreversible reduction of muscle mass and strength, is a
widely documented process35, due to the numerical re-
duction of motoneurones and atrophy of muscle fibres,
above all the IIa type. The process is more marked in
men42 and in the appendicular component43. With age,
there is also adipose infiltration of the muscle mass,
which helps reduce motor efficiency. The aetiology of
sarcopenia is not completely clear. The most important
proposed causal factors are the deterioration of neuro-
muscular functionality, the decline of muscle fibre con-
tractility, variations in the levels of anabolic hormones,
apoptosis and traumas. A sedentary lifestyle, smoking
and an inadequate intake and/or reduced use of proteins
contribute to the progression of sarcopenia.
Sarcopenia causes a significant decrease of motor per-
formance and can become clinically important. It can ac-
tivate a course of involution that causes the clinical syn-
drome of frailty, an invalidating condition associated
with functional decline that exposes the elderly person to
the risk of serious complication, loss of self-sufficiency
and institutionalization. The risk is greater when elderly
people are simultaneously sarcopenic and obese, as shown
by The New Mexico Aging Process Study34.
The standard method for determining the level of
sarcopenia is DXA (dual-energy x-ray absorptiometry). A
diagnostic threshold can be identified using the skeletal
muscle mass index (appendicular muscle mass divided by
height squared, kg/m2), i.e. the value 2 standard devia-
tions below the mean of young adults. Baumgartner et
al.44 calculated corresponding cut-off values of 7.26 kg/m2
for men and 5.45 kg/m2 for women in the cross sectional
New Mexico Elder Health Survey. The prevalence of
sarcopenia in the over-80 population was 53% in men
and 43% in women. On the basis fat-free mass estimates
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by bioelectric impedance analysis, a lower prevalence of
sarcopenia (16% in men, 13% in women) was found in the
over-85 sample from the Rancho Bernardo study45.
However, DXA, like other imaging techniques (CT,
NMR) and biochemical indicators, cannot easily be used
in routine investigations and is thus unsuitable for screen-
ing and monitoring of the nutritional status of the el-
derly. In contrast, other techniques (anthropometry, bio-
electrical impedance, dynamometric and motor tests)
have the advantage of being simple, economical and
non-invasive. The conventional bioimpedance method
can be used to estimate the appendicular muscle mass.
Nevertheless, the predictive efficacy of the BIA regres-
sion equations is significantly influenced by age, sex,
population, health status and validation method. Even
the use of age-specific equations can lead to substantial
estimation errors. Indeed, aged subjects show great indi-
vidual variability in the density of mineral mass, hydra-
tion and protein content of FFM. The alternative ap-
proach of bioelectrical impedance vector analysis (BIVA)
is potentially more accurate, as it is not based on regres-
sion equations46. BIVA has been effectively used to de-
scribe physiological ageing47. However, the definition of
cut-off values is required for validation of the procedure.
Other indicators, such as knee extension isometric tor-
que, handgrip and lower limb muscle power have been
proposed to measure sarcopenia.
Bone mass
The skeletal component of FFM shows important
variations throughout life. Bone mass and density in-
crease until the third decade, after which there is a pro-
gressive decrease, called »osteopenia«11,48,49. According to
Heymsfield et al.40, the mineral content of bones in peo-
ple over 65 is 20% less than in 19–34-year-olds. The pat-
tern of variation of the skeletal compartment is similar
in men and women until 50 years (0.7–1% per year); fol-
lowing menopause, the decrease of the quantity and den-
sity of the bones becomes much faster in women (2–3%
per year)11. The rate of bone loss increases in both sexes
after 70 years of age11.
A major cause of osteopenia is estrogen deficiency, al-
though calcium and vitamin D deficiencies and second-
ary hyperparathyroidism may also contribute to the pa-
thogenesis. Family history, alcohol consumption, smoking
habits, physical activity and nutritional factors have
been shown to affect bone mineral density (BMD), di-
rectly or indirectly49. The body weight, particularly ap-
pendicular skeletal muscle mass, and the BMI are posi-
tively correlated with bone density50,51. A low BMI repre-
sents a risk factor for fracture, as recently confirmed by
the Canadian Multicentre Osteoporosis Study52. This as-
sociation seems to be directly related to mechanical load
forces on bone53. The effect of fat mass on bone is less
clear. However, the Longitudinal Aging Study Amster-
dam showed that FM is associated with BMD54.
Osteopenia may turn into osteoporosis, a disease cha-
racterized by low bone mass and structural deterioration
of bone tissue, which can lead to bone fragility, and an in-
creased susceptibility to fractures of the hip, spine and
wrist. The NHANES I epidemiologic follow-up study55
and the NILS-LSA longitudinal study56 showed a signifi-
cant relationship between BMD and mortality risk. The
loss of height due to osteoporosis, associated with senile
kyphosis, compression of the intervertebral discs and
other pathologies, has been quantified as 0.5–5 cm per
decade (see the discussion of this topic by Perissinotto et
al.33). According to the WHO57, osteoporosis is defined as
a BMD that lies 2.5 standard deviations or more below
the mean value for young healthy women. The gold stan-
dard for the diagnosis of osteoporosis is DXA.
Body water
Physiological ageing is associated with several chan-
ges that may affect water balance and expose older
adults to the risk of dehydration. These changes include
the decline in renal function and thirst perception, and
the reduction of total body water (TBW). Body water de-
creases in parallel with the reduction of FFM, especially
the intra-cellular compartment58. Heymsfield et al.40 es-
timated a TBW reduction of 12% in people over 65 with
respect to 19–34-year-olds. As reviewed by Schoeller59,
TBW is relatively constant until middle age and then be-
gins to decline. In men, the loss is 0.3 kg/year until 70–80
years, while in women it is more intense, especially after
age 70 (0.7 kg/year). Literature data on the level of hy-
dration of FFM (ratio between TBW and FFM) are not
sufficient to provide a definitive picture. As reviewed by
Wang et al.60, controversy exists as to whether FFM
hydration is influenced by age. According to Heymsfield
et al.40, the hydration of FFM passes from 72.1% in
young adults to 71.2% in the elderly. In contrast to
Heymsfield’s data40, Baumgartner et al.61 and Bossing-
ham et al.62 found that the TBW/FFM ratio was lower in
the younger subjects than in the older ones.
Despite the strong influence of dehydration on health
and disease, it is generally under-diagnosed63. While an
increased volume of fluids is associated with oedema, a
reduced volume does not result in evident and specific
clinical manifestations, especially in mild and moderate
cases. The difficulty of diagnosis is even greater in el-
derly subjects, since physical signs of dehydration (e.g.
reduced skin turgor and orthostatic hypotension) are of-
ten present in normally hydrated older people. Biochemi-
cal parameters of dehydration (serum concentrations of
sodium, urea and creatinine, urea/creatinine ratio, osmo-
lality) are also of limited value in monitoring the fluid
balance in aged individuals because of their variability
and a lack of diagnostic standardization.
The gold standard method for the assessment of total
body water (TBW) and extracellular and intracellular
water is based on the dilution principle. Nevertheless, di-
lution methods are rather expensive, time-consuming
and not readily available. Hence, they are not suitable for
use in routine clinical practice. Bioelectrical impedance
analysis, and its variants MFBIA (multi-frequency BIA)
and BIS (bioelectrical impedance spectroscopy) can be
valuable tools to assess changes in body hydration. How-
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ever, the medical applications of the conventional BIA
are limited by the already discussed problem of the speci-
ficity of the equations. Besides, the vector approach
(BIVA) has proved particularly useful to detect hydration
status in all pathological conditions with alterations of
the water compartment46.
Age – Related Fat Mass Variations
Fat mass increases progressively during adulthood be-
cause of the reduction of overall energy expenditure. Ac-
cording to the longitudinal study by Hughes et al.29, in
the 7th decade, FM increases similarly in both sexes
(7.5%). The mixed protocol adopted by Ding et al.27
shows that there is a decrease of fat accumulation at
about 80 years of age, which is more accentuated in wo-
men than in men. This causes a reduction of the sexual
dimorphism typical of adulthood (more fat mass in wo-
men).
Ageing is typically associated with an increase of the
visceral fat component. In both sexes, marked fat redis-
tribution occurs between 45 and 54 years32. Men show a
centripetalization and internalization of fat64,65. Women
are characterized by a peripheral distribution of fat (less
visceral adiposity). However, the sex steroid hormone
changes associated with menopause induce a more an-
droid fat distribution66. Few studies have looked at vis-
ceral fat variations in oldest-old individuals. According to
the cross sectional study of Perissinotto et al.33, waist cir-
cumference decreases significantly in both sexes after 75
years of age. Herrera et al.7 found a reduction of sexual
dimorphism.
The subcutaneous fat component, which increases
until the 7th decade, tends to decrease thereafter67,68.
The EURONUT SENECA longitudinal investigation sho-
wed that age-changes in skinfold thickness are small69.
The variations in fat patterning between males and fe-
males and among different age groups are still not well
defined. A cross sectional study by Buffa et al.70 showed
that the typical dimorphic distribution of subcutaneous
fat (peripheral in women, central in men) changes with
age and becomes more homogeneous in the two sexes.
Herrera el al.7 found that males and females appear to be
more similar for triceps, subscapular and suprailiac skin-
folds at advanced ages.
From the clinical point of view, the regional modifica-
tions of fat mass are most remarkable. A central pattern
of fat distribution is associated with the most important
cardiovascular risk factors, predisposes to metabolic syn-
drome and contributes to the worsening of respiratory
functions. This relationship is confirmed by various epi-
demiological studies. The Normative aging study showed
a significant relation between abdominal fat and cardio-
vascular and diabetes risk71. The Rotterdam study sho-
wed that waist circumference may have more potential
as a predictor of all-cause mortality than the BMI72. The
Health, Aging And Body Composition Study showed that
abdominal obesity and hyperglycaemia are predictive of
mobility limitations in the elderly73.
Variations of visceral fat are described by means of
DXA, imaging techniques and anthropometric indicators
(circumference and sagittal diameter of the waist, waist-
-to-hip ratio, conicity index). There are sex-specific cut-
-offs for estimating visceral obesity based on waist cir-
cumference (88 cm women; 102 cm men)74. However,
age-related differences in body fat distribution may over-
estimate visceral obesity in elderly individuals. On the
basis of waist circumference, over 75% of the elderly
women examined in the Italian Longitudinal Study on
Aging (ILSA) were obese33. The results of the Rotterdam
Study indicated that cut-offs based on analyses of mid-
dle-aged and younger adults are only useful to a limited
degree in older populations75.
Conclusion
The pattern of qualitative variations of body composi-
tion in old age is fairly well defined. During adulthood,
the physiological variation of body mass involves an ini-
tial increasing phase followed by a decreasing trend. The
reduction is due mainly to the loss of fat-free mass.
Sarcopenia is the major causal factor of the FFM loss,
particularly in men. These phenomena are associated with
a decrease of total body water, especially the intra-cellu-
lar compartment. Bone mass also tends to decrease, espe-
cially in women. Fat mass, both the visceral and subcuta-
neous components, increases throughout adulthood, al-
though it tends to decrease in advanced age, mainly due
to a reduction of subcutaneous fat. All these modifications
expose the elderly person to the risk of malnutrition.
The quantitative aspects of the age of onset, rate and
intensity of the physiological variations are still not com-
pletely clear, and there are various reasons for this poor
definition. One problem is the limited number of empiri-
cal observations in oldest-old individuals and the paucity
of cross-cultural studies. However, the main difficulty is
the variable and multifactorial phenomenology of ageing.
Meta-analyses aimed at a detailed definition of the physi-
ological variations of body composition are hindered by
the intrinsic heterogeneity of the ageing process and by
the need to consider numerous significant confounding
factors. Moreover, there is a lack of methodological stan-
dardization of the assessment techniques, as well as diffi-
culty in interpreting and integrating the information de-
riving from cross sectional and longitudinal studies.
The poor quantitative definition of the physiological
variations makes it difficult to define cut-off values indi-
cating the transition to pathological conditions, which
are necessary to develop preventive strategies for body
composition-related diseases in old age. Further research
on healthy elderly men and women from different ethnic
groups, particularly the over-80 population, and the ap-
plication of mixed models for cross sectional-longitudinal
studies will help to better define the vague boundary be-
tween physiology and pathology.
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VARIJACIJE U TJELESNOJ KOMPOZICIJI S OBZIROM NA STARENJE
S A @ E T A K
Fiziolo{ke varijacije u tjelesnoj kompoziciji s obzirom na dob podrazumijevaju i nemasno i masno tkivo. One izla`u
starije osobe riziku od pothranjenosti i mogu dovesti do invaliditeta. Cilj ovog rada je dati pregled trenutnih spoznaja o
tjelesnoj kompoziciji u starijoj populaciji. Obrazac kvalitativnih varijacija u tjelesnoj kompoziciji kod starijih osoba je
relativno dobro definiran. U odrasloj dobi, fiziolo{ke varijacije tjelesne mase uklju~uju prvotnu fazu pove}anja, koju
slijedi trend smanjenja mase. Do smanjenja dolazi prvenstveno zbog gubitka nemasnog tkiva, pogotovo mi{i}ne mase.
Tako|er se smanjuje udio vode i ko{tanog tkiva u tijelu. Masno tkivo se tako|er reducira, za {to se zaslu`nim smatra
prvenstveno gubitak potko`ne masti. Kvantitativni aspekti koji uklju~uju dob po~etka fiziolo{kih varijacija te njihovu
u~estalost i intenzitet jo{ uvijek nisu posve razja{njeni. Razlog tome je varijabilnost i multifaktorska fenomenologija
starenja, heterogenost tehnika procjenjivanja i modela uzorkovanja te ograni~en broj empiri~kih opa`anja kod pojedi-
naca starije dobi.
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